Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Oct;52(4):601-7.
doi: 10.1161/HYPERTENSIONAHA.105.063651. Epub 2008 Sep 8.

Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations

Pál Pacher  1 , Partha Mukhopadhyay, Rajesh Mohanraj, Grzegorz Godlewski, Sándor Bátkai, George Kunos
Affiliations
Review

Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations

Pál Pacher et al. Hypertension. 2008 Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of CB1 receptor activation with potential relevance to cardiovascular diseases/risk.
Figure 2
Figure 2
Therapeutic targets of CB2 receptor stimulation in ischemia/reperfusion injury and atherosclerosis. CB2 agonist decrease endothelial cell activation and inflammatory response, chemotaxis, and adhesion of inflammatory cells (lymphocytes, neutrophils, and/or monocytes) to activated endothelium, transendothelial migration of inflammatory cells, attachment to parenchymal cells and activation, and smooth muscle cell proliferation/migration.
See this image and copyright information in PMC

References

    1. Begg M, Pacher P, Batkai S, Osei-Hyiaman D, Offertaler L, Mo FM, Liu J, Kunos G. Evidence for novel cannabinoid receptors. Pharmacol Ther. 2005;106:133–145. - PubMed
    1. Mackie K, Stella N. Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS Journal. 2006;8:298–306. - PMC - PubMed
    1. Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58:389–462. - PMC - PubMed
    1. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov. 2008;7:438–455. - PubMed
    1. Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A. 2008;105:2699–2704. - PMC - PubMed

Publication types

MeSH terms